Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CFO Alexis Desieno sold 7,487 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total transaction of $23,059.96. Following the completion of the transaction, the chief financial officer now owns 97,849 shares in the company, valued at $301,374.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Cardlytics Trading Down 1.3 %
CDLX opened at $3.07 on Thursday. The firm’s fifty day moving average is $4.56 and its two-hundred day moving average is $8.59. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.77 and a current ratio of 1.77. Cardlytics, Inc. has a twelve month low of $2.89 and a twelve month high of $20.52. The firm has a market cap of $149.76 million, a PE ratio of -0.69 and a beta of 1.68.
Cardlytics (NASDAQ:CDLX – Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.12. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The company had revenue of $69.64 million during the quarter, compared to the consensus estimate of $75.39 million. During the same quarter in the prior year, the firm earned ($0.57) earnings per share. The firm’s revenue was down 9.2% compared to the same quarter last year. Equities research analysts anticipate that Cardlytics, Inc. will post -1.72 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Cardlytics
Institutional Investors Weigh In On Cardlytics
Several large investors have recently made changes to their positions in CDLX. Canton Hathaway LLC grew its stake in Cardlytics by 95.7% in the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock valued at $37,000 after purchasing an additional 2,200 shares in the last quarter. XTX Topco Ltd bought a new position in Cardlytics in the second quarter valued at approximately $107,000. Banco Santander S.A. bought a new position in Cardlytics in the first quarter valued at approximately $199,000. Quest Partners LLC grew its stake in Cardlytics by 160.4% in the second quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after purchasing an additional 11,061 shares in the last quarter. Finally, Clear Street Markets LLC bought a new position in Cardlytics in the fourth quarter valued at approximately $199,000. Institutional investors own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- How to Plot Fibonacci Price Inflection Levels
- 3 Oversold Stocks with Big RSI Rebound Potential
- What is MarketRankā¢? How to Use it
- Joby Aviation Soars With Toyota Investment and Analyst Support
- What is Put Option Volume?
- 3 Stocks Set to Benefit from Cooling Inflation Trends
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.